Novartis Investigative Site

Fairfield, Ohio 45014

0 studies enrolling now · 2 studies all time

What they study most

Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration

Studies at this site

• Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections — Stopped early
• Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD — Completed